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New Zealand’s ‘Approach’ To Invasive Coronary Angiography: A Nationwide
Analysis Of Arterial Access Practices And Outcomes
Peter R. Barr1, Charmaine Flynn1, David Smyth2
1Counties Manukau Health, Auckland, 2Canterbury District Health, Christchurch,
CO
Background: Radial (RA) and femoral arterial access (FA) rates for invasive coro-
nary angiography (ICA) vary widely internationally. RA may reduce bleeding and
acute ST-segment elevation myocardial infarction (STEMI) mortality. European
guidelines recommended default RA. We aim to compare access practices and out-
comes across all hospitals and among all cardiologists within New Zealand’s (NZ)
public sector.
Methods: Patient characteristics, procedural details, and inpatient outcome data was
collected on consecutive patients undergoing ICAs over a 5 month period ending
March 2014. The registry captured all 12 public hospitals that perform ICA in NZ. If
monthly data completion was less than 90% that month was excluded from analysis
and the previous month’s data was used.
Results: Of the 5894 ICAs 81.4% were via RA. Hospitals averaged 25 – 175.6
procedures/month, 46.5% – 96.4% via RA. Operators averaged 13.5 (SD10.2) RA
and 3.5 (SD2.5) FA procedures/month. Those performing > 20 ICAs/month had RA
rates between 61% – 99%. No FA predominant operator performed > 15 ICAs/month.
Of the 75 operators, 69% met RA guidelines; a further 10.7% had suboptimal RA
rates. RA patients were younger (64.5 v 65.8yo, p< 0.0001); rates were higher in
suspected non ST elevation acute coronary syndrome (83.7% v 81.4%, p< 0.0001),
but not acute STEMI (79.3% v 81.4%). Ethnic differences in RA rate were identiﬁed;
Maori 74.4% v Asian people 89.2% (p< 0.0001). RA was lower in outpatients, prior
CABG, and those requiring intra-aortic balloon pump, or rotablation. All-cause
inpatient mortality was lower with RA (0.5% v 2.1%, p< 0.0001), as was bleeding
(1% v 3.5%, p< 0.0001) including TIMI major (0.1% v 0.4%) and TIMI minor
(0.04% v 0.5%) bleeding. Length of stay was no different.
Conclusions: NZ has one of the worlds highest reported RA rates. Over 10% of
operators could alter practices to meet RA recommendations. Despite the strongest
evidence, RA rates were not increased in acute STEMI. There is an unexplained ethnic
disparity in RA rates. Afﬁrming previous reports, inpatient outcomes were better for
RA than FA patients. These ﬁndings highlight an opportunity to modify current
practices to reduce disparities and improve patient outcomes.TCT-824
Patent Hemostasis Rapid Deﬂation Technique to Reduce Radial Artery
Occlusion
Ahmad Edris1, Jonathan Gordin1, Tamer Sallam1, Sheba Meymandi1,
Mahmoud Traina1
1David Geffen School of Medicine at UCLA, Sylmar, CA
Background: Achieving patent hemostasis after transradial catheterization is the most
important factor in reducing radial artery occlusion (RAO) and is limited by larger
sheaths and antithrombotic agents. We sought to evaluate a novel deﬂation technique
to achieve patent hemostasis and reduce RAO.
Methods: 115 patients undergoing transradial catheterization were evaluated in this
retrospective study. Patency of the ulnopalmar arch was evaluated using a Barbeau
test. A 6-French sheath was placed using a modiﬁed Seldinger technique. A combi-
nation of nitroglycerin 200mcg, verapamil 2.5mg, and unfractionated heparin
50units/kg (maximum 5,000 units) was administered into the radial artery. At the
completion of the procedure, the radial artery sheath was withdrawn and a
compression TR band (Terumo Medical, Tokyo, Japan) applied. The TR band was
placed according to standard protocol, documenting hemostasis. Standard technique
(n¼56): Patent hemostasis was not assessed and TR band maintained for 2 hours and
removed. Rapid deﬂation technique (RDT) (n¼59): 15 minutes after TR band
application, radial artery patency was evaluated using a reverse-Barbeau test with
occlusion of the ulnar artery. The TR band was then deﬂated to the lowest allowable
volume (minimum 7mL) while maintaining hemostasis. TR band was then maintained
2 hours and removed. Radial artery patency was evaluated at 24 hours using a reverse-
Barbeau test.
Results: The majority (64%) of the patients (n¼115) presented with acute coronary
syndrome and 38% underwent coronary intervention. At baseline, patent hemostasis
was present in 44% of patients in the RDT arm. After the TR band volume
was lowered an average of 5mL, the rate of patent hemostasis increased to 92%. No
access site complications were noted in either group. The rate of RAO was signiﬁ-
cantly lower in the RDT group compared to standard technique (3.4% vs. 16%,
p¼0.02).
Conclusions: The goal of this study was to evaluate whether a novel deﬂation
technique after transradial catheterization could consistently achieve patent hemostasis
and reduce RAO. Patent hemostasis was achievable in almost all patients undergoing
RDT and associated with a signiﬁcant decrease in RAO at 24 hours.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/VasculTCT-825
Bleeding events are reduced and survival improved by use of radial access during
primary percutaneous coronary intervention for patients receiving glycoprotein
inhibitors
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Nick E. West2
1University of Cambridge, Cambridge, United Kingdom, 2Papworth Hospital,
Cambridge, United Kingdom
Background: Use of glycoprotein IIb/IIIa inhibitors (GPI) during primary percuta-
neous coronary intervention (PPCI) for ST-segment elevation myocardial infarction
(STEMI) is known to improve myocardial perfusion and reduce further ischemic
events, but is associated with an increase in bleeding risk. Performing PPCI via radial
access (rPPCI) is thought to reduce post-procedural bleeding complications and may
improve overall survival. We sought to assess whether rPPCI is associated with
improved outcomes in patients receiving GPI at our institution.
Methods: Consecutive patients undergoing PPCI for STEMI over a four-year period
were included. All patients were preloaded with 600mg clopidogrel and 300mg aspirin
en-route to PPCI. Interventional strategy and GPI use were left to operator discretion.
Patient data and outcome measures were obtained by interrogation of notes and na-
tional databases. Bleeding complications were categorized using Bleeding Academic
Research Consortium (BARC) deﬁnitions.
Results: 2,019 patients were included in the analysis (mean age 64.212.4yrs, 75.9%
male), with 863 receiving GPI. Patients that received GPI were younger
(62.711.8yrs vs. 64.812.6yrs, p< 0.001), more likely to be male (80.5% vs.
73.9%, p< 0.001) but had a higher incidence of cardiogenic shock (5.6% vs. 2.7%,
p¼0.002). Other baseline demographics were similar. Overall, BARC deﬁned
bleeding was more prevalent in those receiving GPI (BARC 2 3.0% vs. 0.7%, p<
0.001; BARC 3 2.6% vs. 0.2%, p< 0.001). However, patients undergoing rPPCI
with GPI had lower bleeding rates when compared with femoral access (0.8% vs.
3.7%, p¼0.05). For patients receiving GPI, rPPCI resulted in a signiﬁcant improve-
ment in 1-year survival (99.2% vs. 93.5%, p¼0.01; OR 0.12, 95%CI 0.02-0.87,
p¼0.04). However, in patients not receiving GPI, no survival beneﬁt for rPPCI was
observed (94.4% vs. 93.7%, p¼0.70; OR 0.87, 95%CI 0.44-1.71, p¼0.69).
Conclusions: rPPCI results in lower rates of bleeding and improved survival in pa-
tients receiving GPI during PPCI. rPPCI should be considered in patient groups where
subsequent use of GPI is likely.
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The Consequence Of Transradial Coronary Catheterization On Upper
Limb Function
Maarten van Leeuwen1, Nicolas M. Van Mieghem2, Guus d Waard3,
Paul F. Teunissen4, Niels van Royen4
1VU Medical Center, Rotterdam, Nederland, 2Erasmus MC, Rotterdam, Netherlands,
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Background: It is currently unknown if upper limb function is affected by trans-
radial(TR) catheterization. We aimed to study the change of upper limb function when
percutaneous coronary procedures were performed through the radial artery
Methods: Between Jan. 2013 and Feb. 2014 upper limb function was assessed in a
total of 338 all-comer patients undergoing catheterization in an ambulatory setting
(85% radial,15% femoral). Upper limb function was assessed with the self-reported
shortened version of the disabilities of arm, shoulder, and hand (QuickDASH)
questionnaire, which has been validated in a normative population and a variety of
conditions. It consists of 11 items to measure physical function, symptoms and
its consequences on daily life. A high score indicates a worse upper limb function.
Upper extremity cold intolerance was assessed with the self-reported CISS ques-
tionnaire. Cold intolerance is associated with functional impairment and reduced
quality-of-life. It is a common consequence of upper extremity injuries, especially
when neurovascular structures are involved. Both questionnaires were completed
before the catheterization and at 30 days F-up. The non-parametric Wilcoxon signed-
rank test was used to assess the change of upper limb function and symptoms over
time.
Results: The QuickDASH at baseline was the same in both access groups(p¼0.28)
with signiﬁcantly higher scores in females(p< 0.001) and elderly (p¼ 0.015). Upper
limb function did not change signiﬁcantly over time when catheterization was per-
formed through the radial artery(p¼0.06). Though, a trend to a lower QuickDASH
scores was observed at F-up, mainly driven by the symptom section of the ques-
tionnaire. Newly developed upper extremity complaints that persisted for 30 days F-
up were equal between both access routes (TR 10.5%,TF 11.5%; p¼0.82). Extremity
pain was the most frequent persisting complaint after TR procedures (4.5%). The
upper extremity was not affected by cold intolerance after TR catheterization(p¼0.91).
The scores for cold intolerance(p¼0.96) and upper limb function(p¼0.19) were not
affected by TF access.
Conclusions: Upper limb function was not affected when coronary procedures were
performed through the radial artery.ar Access and Intervention - Transradial B241
